CDMO Molecular Profiles says that it has hired Charles D. Maher as head of US sales in order to “increase awareness and uptake of its pharmaceutical development services in the North American market.” The company’s services include formulation development and clinical trial manufacturing of dry powder inhalers.
Molecular Profiles CEO Nikin Patel commented, “Over the years, we have built a solid reputation in Europe for applying a science driven approach to our clients’ development challenges in a cost-effective manner that delivers value by accelerating development. We are now striding toward executing our strategy to replicate this success in the United States.”
Read the Molecular Profiles press release.
